IMM 11.9% 29.5¢ immutep limited

announcements on the way?

  1. 4,906 Posts.
    lightbulb Created with Sketch. 343
    within the very near future, (week , month or 2 months)?


    *More funding?

    *SPP

    *Big Pharma partner/takeover?

    *US FDA grant of Investigational New Drug Application for
    CVac™

    *commencement of Pivotal Clinical Trial


    *Divestment of 3 non-core assets?
    -Oncomab Pty Ltd (monoclonal antibody for the anti-cancer
    Cripto-1)
    – Anthron(Trillium Therapeutics Inc.)
    – Panvax Pty Ltd


    An old announcement but how relevant to were we are today.........


    Prima swooped on by Peregrine
    Jeremy Torr 27/08/2003 15:06:06 Investment bank Peregrine Corporate has upped its stake in Prima BioMed to around 14 per cent on the back of a AUD$7.2 million share placement of 11.62 million ordinary shares.

    The issue has raised around $4.5 million to be used directly for the instigation of Phase II trials on its Cancer Vac dendritic cell priming immunotherapy compound. According to Prima executive chairman Bryan Frost, the remainder will be allocated to the company's other R&D areas, including its work on arthritis therapeutics.

    "We are off to the races now -- it has not been easy for the last six months, but this raising shows the market is changing and that's good for us and good for the biotech sector. More investors are coming in to the industry now," he said.

    The Phase II trials will build on the positive results from Ib, when four advanced cancer patients were successfully treated with the CancerVac therapeutics.

    Frost said the company was in ongoing negotiations with big pharma about commercialisation of the compound, and that talks were also being held on the future of the arthritis treatment.

    "We have four major research projects all alive and well, and this money will allow us to investigate joint ventures with overseas companies too. The extra money reflects a significant turnaround in the market, and will let our guys get on with the job," he asserted.


    https://www.biotechnews.com.au/article/49587/prima_swooped_by_peregrine

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.040(11.9%)
Mkt cap ! $428.5M
Open High Low Value Volume
32.0¢ 33.0¢ 28.0¢ $7.278M 23.75M

Buyers (Bids)

No. Vol. Price($)
4 53192 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 41048 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.